RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial availability of the UltraMarathonRT ® Direct RNA‑Seq (uMRT DRS) Kit, a ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...
Rapid advances in sequencing technologies have transformed our ability to diagnose human genetic disorders, yet many patients still lack a molecular ...
The Cancer Genome Atlas Pilot Project is a three-year, $100 million collaboration to test the feasibility of using large-scale genome analysis technologies to identify important genetic changes ...
DYN G.S. is aiming to become a specialized center for providing sequencing services. with the Breaking Science News daily newsletter ...